Papamargaritis, Dimitris

What is the pipeline for future medications for obesity?

Melson, E., Ashraf, U., Papamargaritis, D., & Davies, M. J. (2025) · International Journal of Obesity

Pharmacology and Obesity TreatmentRegulation of Appetite and Obesity

Cited by 332

Efficacy and Safety of Tirzepatide in Type 2 Diabetes and Obesity Management

Sinha, R., Papamargaritis, D., Sargeant, J. A., & Davies, M. J. (2023) · Journal of Obesity & Metabolic Syndrome

Diabetes Treatment and ManagementPharmacology and Obesity Treatment

Cited by 138

Dumping Symptoms and Incidence of Hypoglycaemia After Provocation Test at 6 and 12 Months After Laparoscopic Sleeve Gastrectomy

Papamargaritis, D., Koukoulis, G., Sioka, E., Zachari, E., Bargiota, A., Zacharoulis, D., & Tzovaras, G. (2012) · Obesity Surgery

Bariatric Surgery and OutcomesMinimally Invasive Surgical Techniques

Cited by 112

Symptoms Suggestive of Dumping Syndrome After Provocation in Patients After Laparoscopic Sleeve Gastrectomy

Tzovaras, G., Papamargaritis, D., Sioka, E., Zachari, E., Baloyiannis, I., Zacharoulis, D., & Koukoulis, G. (2012) · Obesity Surgery

Bariatric Surgery and OutcomesMinimally Invasive Surgical Techniques

Cited by 97

New therapies for obesity

Papamargaritis, D., le Roux, C. W., Holst, J. J., & Davies, M. J. (2024) · Cardiovascular Research

Pharmacology and Obesity TreatmentRegulation of Appetite and Obesity

Cited by 73

Do Gut Hormones Contribute to Weight Loss and Glycaemic Outcomes after Bariatric Surgery?

Papamargaritis, D., & le Roux, C. W. (2021) · Nutrients

Bariatric Surgery and OutcomesRegulation of Appetite and Obesity

Cited by 68

The Effects of Glucagon-Like Peptide-1 Receptor Agonists on Mitochondrial Function Within Skeletal Muscle: A Systematic Review

Old, V. J., Davies, M. J., Papamargaritis, D., Choudhary, P., & Watson, E. L. (2025) · Journal of Cachexia, Sarcopenia and Muscle

Diabetes Treatment and ManagementMuscle Physiology and Disorders

Cited by 55

Future therapies for obesity

Melson, E., Miras, A. D., & Papamargaritis, D. (2023) · Clinical Medicine

Pharmacology and Obesity TreatmentBariatric Surgery and Outcomes

Cited by 46

Oral glucagon-like peptide-1 receptor agonists and combinations of entero-pancreatic hormones as treatments for adults with type 2 diabetes: where are we now?

Gogineni, P., Melson, E., Papamargaritis, D., & Davies, M. (2024) · Expert Opinion on Pharmacotherapy

Diabetes Treatment and ManagementPharmacology and Obesity Treatment

Cited by 32

Impact of weight loss and weight gain trajectories on body composition in a population at high risk of type 2 diabetes: A prospective cohort analysis

Yates, T., Biddle, G. J. H., Henson, J., Edwardson, C. L., Arsenyadis, F., Goff, L. M., Papamargaritis, D., Webb, D. R., Khunti, K., & Davies, M. J. (2024) · Diabetes, Obesity and Metabolism

Obesity, Physical Activity, DietDiabetes, Cardiovascular Risks, and Lipoproteins

Cited by 31

Triple Agonism Based Therapies for Obesity

Goldney, J., Hamza, M., Surti, F., Davies, M. J., & Papamargaritis, D. (2025) · Current Cardiovascular Risk Reports

Diabetes Treatment and ManagementPharmacology and Obesity Treatment

Cited by 22